Relative efficacy of inactivated bovine herpesvirus-1 (BHV-1) vaccines

Vaccine

Volumn 23, Issue 31, 2005, Pages 4054-4061

  Patel, J R ^a,b  

^a Walton Manor   (United Kingdom)

^b JAS Biologicals ^*  (United Kingdom)

Author keywords

Bovine herpesvirus 1; Cattle respiratory disease; Infectious bovine rhinotracheitis; Killed vaccines' efficacy

Indexed keywords

IBEPUR; IFFAVAX; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BOVINE HERPES VIRUS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; COW; FEMALE; HERPES VIRUS INFECTION; INFECTION PREVENTION; MALE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; FEMALE; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; INJECTIONS, INTRAMUSCULAR; MALE; VACCINES, INACTIVATED; VIRUS SHEDDING;

EID: 20444375427     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.010     Document Type: Article

References (16)

1. Gibbs EPJ, and Rweyemamu Bovine herpesvirus. Part I. Bovine herpesvirus Vet Bull 47 1997 317 343
2. R.F. Kahrs Infectious bovine rhinotracheitis; a review and update J Am Vet Med Assoc 171 1977 1055 1064
3. Yates, WDG. A review of infectious bovine rhintotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 1982;46:225-63.
4. Kendrick JW, York CJ, McKercher DG. A controlled field trial of a vaccine for infectious bovine rhinotracheitis. Proc US Livestock Sanitary Assoc 1956;60:155-158.
5. O.C. Straub BHV-1 infections: relevance and spread in Europe Comp Immun Microbiol Infect Dis 14 1991 175 186
6. J.T. Van Oirschot, MJ. Kaashoek, and F.A.M. Rijsewijk Advances in the development and evaluation of bovine herpesvirus 1 vaccines Vet Microbiol 53 1996 43 54
7. MJ. Kaashoek, and J.T. Van Oirschot Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine Vet Microbiol 53 1996 191 197
8. W. Strube, S. Auer, W. Block, E. Heinen, D. Kretzdorn, and C. Rodenbach A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs Vet Microbiol 53 1996 181 189
9. G.N. Frerichs, S.B. Woods, MH. Lucas, and J.J. Sands Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines Vet Rec 111 1982 116 122
10. M. Lazarowicz, F. Steck, M. Ackermann, and U. Kihm Testing of two vaccines against infectious bovine rhinotracheitis Schweizer Arch Tierheilkd 125 1983 797 808
11. W. Strube, S. Auers, B. Abar, R.D. Bergle, W. Block, and E. Heinen Infectious bovine rhinotracheities marker vaccines - chemically inactivated and live attenuated - for the improvement of BHV-1 control programs II. Evaluation of immunogenicity Proceedings of the XVIII World Buiatrics Congress, Bologna 1994 761 764
12. Patel JR. Characteristics of live bovine herpesvirus-1 (BHV-1) vaccines. Vet J 2005;169(3):404-16.
13. O.C. Straub Advantages and disadvantages of common vaccination programmes for cattle M. Kaske H. Scholz M. Höttershinken Recent developments and perspective in bovine medicine XXII World Buiatrics Congress 2002 Hannover Germany 86 96
14. M.J. Kaashoek, A. Moerman, J.A. Madic, K. Weerdmeester, M.A. Maris-Veldhuis, and FAM. Rijsewijk An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation Vaccine 13 1995 342 346
15. M. Engels, and M. Ackermann Pathogenesis of ruminant herpesviruses Vet Microbiol 53 1996 31 42
16. L.A. Babiuk, S. Van Drunen Little-van den Hurk, and S.K. Tikoo Immunology of bovine herpesvirus 1 infection Vet Microbiol 53 1996 31 42